Cargando…
Reverse Translational Study of Fenofibrate's Observed Effects in Diabetes‐Associated Retinopathy
Clinical trials suggest that fenofibrate reduces the progression of retinopathies in patients with type 2 diabetes. Furthermore, patients with retinopathies have elevated levels of inflammatory chemokines and dysfunctional retinal angiogenesis. Therefore, we investigated the effects of fenofibrate o...
Autores principales: | Farris, RA, Price, ET |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352499/ https://www.ncbi.nlm.nih.gov/pubmed/27996196 http://dx.doi.org/10.1111/cts.12412 |
Ejemplares similares
-
Effects of fenofibrate on inflammatory cytokines in diabetic retinopathy patients
por: Ju, Hai-Bing, et al.
Publicado: (2017) -
Efficacy of fenofibrate for diabetic retinopathy: A systematic review protocol
por: Su, Xing-jie, et al.
Publicado: (2019) -
Should We Start All Patients with Diabetic Retinopathy on Fenofibrates?
por: Koshy, Jacob, et al.
Publicado: (2013) -
Association of Fenofibrate and Diabetic Retinopathy in Type 2 Diabetic Patients: A Population-Based Retrospective Cohort Study in Taiwan
por: Lin, Ying-Chieh, et al.
Publicado: (2020) -
An Update on the Molecular Actions of Fenofibrate and Its Clinical Effects on Diabetic Retinopathy and Other Microvascular End Points in Patients With Diabetes
por: Noonan, Jonathan E., et al.
Publicado: (2013)